President Donald Trump’s early actions on health care signal his likely intention to wipe away some Biden-era programs to lower drug costs and expand coverage under public insurance programs.

Former St. Louis Cardinals manager Mike Matheny spent 20 days in an intensive care unit, where he was diagnosed with a subarachnoid hemorrhage, a serious and potentially life-threatening condition ...

The start of a new year gives older adults with a Medicare health plan an opportunity to think ahead and make a difference in their future.

Researchers utilized the comprehensive score for financial toxicity tool to measure self-reported financial distress among ...

Medicare plans to negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.

Someone who takes a pricey cancer drug, for example ... The coverage gap — or “donut hole” — will finally close The original Medicare Part D benefit had a coverage gap (also called the "donut hole") ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.

NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...